Changrolin

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameChangrolin
Drug Alias NamePyrozoline
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel antagonistsVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channelPotassium channel
Therapy Area/IndicationsArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaDiscontinued
Originator CompaniesShanghai Jiao Tong University School of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShanghai Jiao Tong University School of Medicine
Active IndicationsN/A
Inactive IndicationsArrhythmias, Cardiac

Other Information

ATC CodeN/A
Related LinksN/A